|
(Nephrology Hypertension Journal Club) Optimized Immunosuppression to prevent graft failure in renal transplant recipients with HLA antibodies: April 21, 2023 |
04/21/2023 - 7:30am to 8:30am |
|
(Nephrology Hypertension Journal Club) Sparsentan in Patients with IgA nephropathy: a prespecified interim analysis from a randomized, double-blind, active-controlled clinical trial: April 28, 2023 |
04/28/2023 - 7:30am to 8:30am |
|
(Nephrology Hypertension Journal Club) Inaxaplin for Proteinuric Kidney Disease in Persons with Two APOL1 Variants |
05/05/2023 - 7:30am to 8:30am |
|
Nephrology Hypertension Journal Club: Genetic Variation, Coffee Intake, and Kidney Dysfunction (May 19, 2023) |
05/19/2023 - 7:30am to 8:30am |
|
Nephrology Hypertension Journal Club Comparing Physician and Artificial Intelligence Chatbot Responses to Patient Questions Posted to a Public Social Media Forum : May 26, 2023 |
05/26/2023 - 7:30am to 8:30am |
|
Nephrology Hypertension Journal Club Heterogeneity in Blood Pressure Response to 4 Antihypertensive Drugs A Randomized Clinical Trial : June 2, 2023 |
06/02/2023 - 7:30am to 8:30am |
|
Nephrology Hypertension Journal Club : Endovascular Ultrasound Renal Denervation to Treat Hypertension |
06/16/2023 - 7:30am to 8:30am |
|
Nephrology Hypertension Journal Club Antibody-Guided Therapy in Phospholipase A2 Receptor Associated Membranous Nephropathy June 23, 2023 |
06/23/2023 - 7:30am to 8:30am |
|
Nephrology Hypertension Journal Club : Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence July 30, 2023 |
06/30/2023 - 7:30am to 8:30am |
|
Nephrology Hypertension Journal Club : Sodium bicarbonate for kidney transplant recipients with metabolic acidosis in Switzerland: a multicentre, randomized, single-blind, placebo-controlled, phase 3 trial (July 7, 2023) |
07/07/2023 - 7:30am to 8:30am |
Facebook
Twitter
LinkedIn
Forward